AbbVie

AbbVie’s tavapadon achieves positive topline results in Phase III TEMPO-2 trial
Clinical Trials Arena
Wed, 12/18/24 - 11:20 am
AbbVie
clinical trials
tavapadon
Parkinson's Disease
3 closely watched drugs that failed in the clinic
Pharma Voice
Mon, 12/16/24 - 11:24 am
biotech
Roche
tiragolumab
AbbVie
emraclidine
Cassava Sciences
simufilam
AbbVie to acquire Roche spinout Nimble in immune drug deal
BioPharma Dive
Fri, 12/13/24 - 11:49 am
AbbVie
Nimble Therapeutics
M&A
IL-23
Roche
AbbVie's Parkinson's prospect hits again in phase 3, completing clean sweep to tee up FDA filing
Fierce Biotech
Mon, 12/9/24 - 11:09 am
AbbVie
Parkinson's Disease
tavapadon
FDA
Alector lays off 17% of staff after AbbVie-partnered Alzheimer's asset fails phase 2
Fierce Biotech
Tue, 11/26/24 - 11:05 am
Alector
AbbVie
Alzheimer's disease
clinical trials
layoffs
AL002
What is a ‘cure,’ really? AbbVie’s Humira creator leaps into the next phase of medicine
Pharma Voice
Tue, 11/19/24 - 10:57 am
AbbVie
R&D
virology
AbbVie bags EU nod for key drug from ImmunoGen takeover
Pharmaphorum
Mon, 11/18/24 - 11:10 am
AbbVie
Europe
Elahere
ovarian cancer
Immunogen
Advantage BMS as AbbVie drug fails schizophrenia trials
Pharmaphorum
Mon, 11/11/24 - 11:24 am
AbbVie
emraclidine
schizophrenia
Cerevel Therapeutics
clinical trials
Bristol Myers Squibb
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
Pharma Voice
Thu, 11/7/24 - 11:12 am
M&A
Vertex Pharmacuticals
Alpine Immune Sciences
Eli Lilly
Morphic
Novartis
MorphoSys
Mariana Oncology
AstraZeneca
Fusion Pharmaceuticals
Lundbeck
Longboard Pharmaceuticals
AbbVie
Aliada Therapeutics
AbbVie taps T-cell engager tech from EvolveImmune to build next-gen cancer biologics
First Word Pharma
Thu, 10/31/24 - 09:39 am
AbbVie
EvolveImmune
T-cell engager
AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter Beat
Investors Business Daily
Wed, 10/30/24 - 08:50 pm
AbbVie
earnings
Humira
Skyrizi
AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy
BioSpace
Mon, 10/28/24 - 11:41 am
AbbVie
M&A
Alzheimer's disease
Aliada Therapeutics
AbbVie makes Richter richer, paying $25M to form discovery pact with Vraylar originator
Fierce Biotech
Fri, 10/25/24 - 11:37 am
AbbVie
Vraylar
Gedeon Richter
drug discovery
After rejections, AbbVie secures approval for Parkinson’s drug
BioPharma Dive
Thu, 10/17/24 - 08:52 pm
AbbVie
Parkinson's Disease
Vyalev
FDA
Skyrizi notches top pharma, Rx brand spot for Q3 2024
Medical Marketing and Media
Mon, 10/7/24 - 09:52 pm
AbbVie
Skyrizi
Crohn's Disease
psoriatic arthritis
AbbVie cuts 2024 profit forecast citing R&D expenses
Reuters
Thu, 10/3/24 - 09:26 pm
AbbVie
R&D
Louisiana district court upholds state 340B contract pharmacy law
American Hospital Association
Wed, 10/2/24 - 10:01 pm
legal
Louisiana
340B
contract pharmacies
AbbVie
AstraZeneca
PhRMA
EU withdraws marketing authorisation for Abbvie's hepatitis C drug
Reuters
Wed, 10/2/24 - 11:16 am
AbbVie
Europe
Exviera
hepatitis C
Blue Shield of California bypasses PBMs to slash Humira prices by 90%
Pharmaphorum
Wed, 10/2/24 - 09:37 am
Blue Shield
California
PBMs
AbbVie
Humira
AbbVie seeks FDA approval for non-small cell lung cancer treatment
Pharmaceutical Business Review
Mon, 09/30/24 - 09:45 am
AbbVie
FDA
Teliso-V
non-small cell lung cancer

Pages